The Reverse Stock Split is intended to increase the per-share trading price of the Company’s Common Stock to assist in regaining compliance with the Nasdaq minimum bid price requirement of USD 1.00 ...

MetaVia ( ($MTVA) ) has provided an announcement. On December 2, 2025, MetaVia Inc. announced a 1-for-11 reverse stock split of its common stock, ...

Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that its Board ...

The S&P 500 rose 0.5% on Friday, pushing it near a record set in late October and helping the index eke out a 0.1% monthly ...

Provides update on Merger with Republic Airways Holdings Inc.

Nov 18 (Reuters) - Reverse stock splits globally have climbed to a record this year, underscoring the strain on small-cap companies struggling to stay listed even as an AI-fueled rally lifts ...

Hudson Pacific Properties, Inc. ("Hudson Pacific" or the "Company") (NYSE: HPP) today announced that it will effect a 1-for-7 reverse stock split (the "Reverse Stock Split") of its common stock, par ...

Nov 14 (Reuters) - Sweden's Polestar on Friday said it would conduct a one-for-thirty reverse stock split of its American Depository Shares as the electric vehicle maker seeks to avoid a Nasdaq ...

Polestar reported a wider third-quarter loss on Wednesday and said it would conduct a reverse stock split - reducing the number of its existing shares while increasing their value - in an attempt to ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, announced today that it will ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Enveric Biosciences (ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric ...

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, ...